BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 22336175)

  • 1. Investigation of immunohistochemical ERα, ERβ and ERβcx expressions in normal and neoplastic breast tissues.
    Bozkurt KK; Kapucuoğlu N
    Pathol Res Pract; 2012 Mar; 208(3):133-9. PubMed ID: 22336175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased estrogen receptor betacx expression during mammary carcinogenesis.
    Esslimani-Sahla M; Kramar A; Simony-Lafontaine J; Warner M; Gustafsson JA; Rochefort H
    Clin Cancer Res; 2005 May; 11(9):3170-4. PubMed ID: 15867209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors.
    Roger P; Sahla ME; Mäkelä S; Gustafsson JA; Baldet P; Rochefort H
    Cancer Res; 2001 Mar; 61(6):2537-41. PubMed ID: 11289127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of ERalpha and ERbeta in lobular carcinoma in situ.
    Middleton LP; Perkins GH; Tucker SL; Sahin AA; Singletary SE
    Histopathology; 2007 Jun; 50(7):875-80. PubMed ID: 17543077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma.
    Gruvberger-Saal SK; Bendahl PO; Saal LH; Laakso M; Hegardt C; Edén P; Peterson C; Malmström P; Isola J; Borg A; Fernö M
    Clin Cancer Res; 2007 Apr; 13(7):1987-94. PubMed ID: 17404078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
    APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase 26 proteolysis of the NH2-terminal domain of the estrogen receptor beta correlates with the survival of breast cancer patients.
    Savinov AY; Remacle AG; Golubkov VS; Krajewska M; Kennedy S; Duffy MJ; Rozanov DV; Krajewski S; Strongin AY
    Cancer Res; 2006 Mar; 66(5):2716-24. PubMed ID: 16510592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
    Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
    Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.
    Mylonas I; Makovitzky J; Jeschke U; Briese V; Friese K; Gerber B
    Anticancer Res; 2005; 25(3A):1719-23. PubMed ID: 16033090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical COX-2 overexpression correlates with HER-2/neu overexpression in invasive breast carcinomas: a pilot study.
    Çiriş IM; Bozkurt KK; Başpinar S; Kapucuoğlu FN
    Pathol Res Pract; 2011 Mar; 207(3):182-7. PubMed ID: 21371829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters.
    Wang M; Pan JY; Song GR; Chen HB; An LJ; Qu SX
    Eur J Surg Oncol; 2007 Mar; 33(2):195-201. PubMed ID: 17046193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of estrogen receptor beta wild-type and its variant ERbetacx/beta2 is correlated with better prognosis in breast cancer.
    Sugiura H; Toyama T; Hara Y; Zhang Z; Kobayashi S; Fujii Y; Iwase H; Yamashita H
    Jpn J Clin Oncol; 2007 Nov; 37(11):820-8. PubMed ID: 17932113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression.
    Tezel GG; Uner A; Yildiz I; Guler G; Takahashi M
    Pathol Res Pract; 2009; 205(6):403-8. PubMed ID: 19232840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DEK overexpression is correlated with the clinical features of breast cancer.
    Liu S; Wang X; Sun F; Kong J; Li Z; Lin Z
    Pathol Int; 2012 Mar; 62(3):176-81. PubMed ID: 22360505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer.
    Borgquist S; Holm C; Stendahl M; Anagnostaki L; Landberg G; Jirström K
    J Clin Pathol; 2008 Feb; 61(2):197-203. PubMed ID: 18223096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells.
    Secreto FJ; Monroe DG; Dutta S; Ingle JN; Spelsberg TC
    J Cell Biochem; 2007 Aug; 101(5):1125-47. PubMed ID: 17520659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic correlation of cancer stem cell markers CD44, CD24, VEGF and HIF-1α in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
    Wang Z; Shi Q; Wang Z; Gu Y; Shen Y; Sun M; Deng M; Zhang H; Fang J; Zhang S; Xie F
    Pathol Res Pract; 2011 Aug; 207(8):505-13. PubMed ID: 21802218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of wild-type estrogen receptor beta protein in human breast cancer: specific correlation with HER2/neu overexpression.
    Umekita Y; Souda M; Ohi Y; Sagara Y; Rai Y; Takahama T; Yoshida H
    Pathol Int; 2006 Aug; 56(8):423-7. PubMed ID: 16872435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative profile of estrogen receptor variants/isoforms in Taiwanese women with breast cancer.
    Hsiao WC; Cho WC; Lin PW; Lin SL; Lee WY; Young KC
    Eur J Surg Oncol; 2006 Jun; 32(5):492-7. PubMed ID: 16551498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.